Latest Breaking News On - Fred schwarzer - Page 2 : comparemela.com

IGM Biosciences, Inc (NASDAQ:IGMS) Short Interest Update

IGM Biosciences, Inc (NASDAQ:IGMS) Short Interest Update
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Hudson bayMisbah tahirFred schwarzerPanagora asset management incRoyal bankSecurities exchange commissionBiosciences incIgm biosciences incTd asset management incGet free reportExchange commissionPartners asset managementBay capital managementManagement incPanagora asset managementDeath receptor

IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update

IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesFred schwarzerDavid pittsBiosciences incDevelopment rd expensesExchange commissionChief executive officer

IGM Biosciences (NASDAQ:IGMS) Shares Gap Down to $10 07

IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) shares gapped down prior to trading on Monday . The stock had previously closed at $10.07, but opened at $9.85. IGM Biosciences shares last traded at $9.94, with a volume of 15,541 shares changing hands. Wall Street Analyst Weigh In IGMS has been the subject of a […]

Dekabank deutsche girozentraleFred schwarzerNisa investment advisorsSecurities exchange commissionRoyal bankCapital partnersBiosciences incIgm biosciences incExchange traded conceptsGet free reportStock downAdvisors lp bakerExchange commissionInvestment advisorsTraded conceptsBank deutsche girozentrale

IGM Biosciences (NASDAQ:IGMS) Receives Neutral Rating from HC Wainwright

IGM Biosciences (NASDAQ:IGMS – Get Free Report)‘s stock had its “neutral” rating reissued by equities researchers at HC Wainwright in a report released on Thursday, Benzinga reports. They presently have a $12.00 price target on the stock. HC Wainwright’s price objective suggests a potential upside of 47.60% from the company’s current price. Separately, Royal Bank […]

Misbah tahirFred schwarzerRoyal bankCitigroup incCubist systematic strategiesLazard asset managementBiosciences company profileSecurities exchange commissionNisa investment advisorsEnsign peak advisors incBiosciences incGet free reportStock downExchange commissionAsset managementSystematic strategies

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum

MOUNTAIN VIEW, Calif., April 10, 2024 IGM Biosciences, Inc. , a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief.

Fred schwarzerDavid pittsVirtual targeted oncology forum onBiosciences incChief executive officerTargeted oncology forum